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 ABSTRACT 
Background. Skin microvascular responses to local heating are frequently used to 
assess microvascular function. Several local heating protocols have been developed, 
all varying slightly in execution. The aim of this study was to determine the inter-day 
reproducibility of the four most commonly used local heating protocols in healthy 
young subjects.  
Methods. Fifteen, healthy males (28±5yrs, BMI 25±2kg/m2) attended two 
experimental trials 2-7 days apart. During each trial, baseline and maximal thermally 
stimulated forearm skin responses were examined simultaneously at four sites on the 
dominant forearm using laser Doppler flowmetry (LDF). The following heating 
protocols were adopted: 1. Rapid 39°C (0.5°C/5s), 2. Rapid 42°C (0.5°C/5s) 3. 
Gradual 42°C (0.5°C/2min30s) and 4. Slow 42°C (0.5°C/5min). The coefficient of 
variation (CV) was calculated for absolute flux, cutaneous vascular conductance (CVC; 
flux/mean arterial pressure, MAP) and CVC expressed as a percentage of maximal 
CVC at 44°C (%CVCmax) at three different time points; baseline (33°C), plateau 
(39/42°C) and maximal (44°C). 
Results. Reproducibility of baseline flux, CVC and %CVCmax was 17-29% across all 
protocols. During the plateau, Rapid, Gradual and Slow 42°C demonstrated a 
reproducibility of 13-18% for flux and CVC and 5-11% for %CVCmax. However, Rapid 
39°C demonstrated a lower reproducibility for flux, CVC and %CVCmax (all 21%). 
Reproducibility at 44°C was 12-15% for flux and CVC across all protocols.  
Conclusion. This is the first study examining inter-day reproducibility across four local 
heating protocols. The good-to-moderate reproducibility of the Rapid, Gradual and 
Slow 42°C protocols support their (simultaneous) use to assess microvascular 
function. Using Rapid 39°C may require a greater number of subjects to detect 
differences within subjects.  
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 INTRODUCTION 
Microvascular dysfunction may predict the manifestation of future cardiovascular 
disease, preceding abnormalities in larger conduit arteries and arterioles [1-6]. The 
skin provides an easily accessible site to assess microvascular integrity through non-
invasive methods, which can be used as an index of overall systemic vascular function. 
Control of the cutaneous microcirculation involves both neural and non-neural 
pathways [7]. Neurogenic reflexes and local chemical mediators, such as nitric oxide 
(NO), contribute towards the vasodilatory effect mediated by the vascular endothelium 
during local skin heating [8, 9]. Protocols that locally heat the skin are increasingly 
used in conjunction with laser Doppler flowmetry (LDF) to evaluate skin blood flow 
responses and microvascular function, particularly for comparing between healthy and 
diseased individuals and/or assessing responses to interventions.  
 
There are currently several local heating protocols that are widely used to assess 
cutaneous microvascular function [8, 10, 11]. These protocols all aim to increase skin 
blood flow to maximal/near-maximal levels (39-42°C), but they vary in the rate at which 
the skin is heated (0.5°C  per 5s, 2min30s or 5min) and/or the plateau at which the 
temperature is set (39°C vs 42°C) [8, 10-14]. Due to the differences in the plateau and 
the rate of skin heating, a different contribution of the vasodilator pathways to the local 
heating response is present. Rapid local heating (0.5°C per 5s) induces a transient 
axon-reflex (~5-10 min), produced via activation of heat sensitive sensory nerves and 
adrenergic nerves, followed by a more gradual, sustained vasodilatory response (20-
30 min) that is partly (60-70%) NO-mediated [10]. A modification of this protocol, by 
maintaining the plateau phase at 39°C, is believed to lead to a larger contribution of 
 NO to the plateau phase [11]. Alternatively, gradually heating the skin (0.5°C per 
2min30s or 5min) evokes a largely NO-mediated vasodilatory response, without 
producing an axon-reflex [8, 12].  
 
Previous work found moderate to good inter-day reproducibility for all local heating 
protocols [12, 15-18], especially when data were expressed relative to maximal values 
[12, 15, 18]. However, no previous study examined the reproducibility of these local 
heating protocols within the same subjects and/or simultaneously. This latter aspect is 
of special importance, since simultaneous assessment of distinct heating protocols 
may achieve better insight due to the distinct dilator pathways involved. Therefore, the 
aim of this study was to simultaneously determine the inter-day reproducibility of four 
commonly used local heating protocols for assessing cutaneous microvascular 
function. We expect comparable reproducibility of all four protocols, which would 
facilitate simultaneous use of multiple local heating protocols within the same study. 
 
METHODS 
Participants 
Fifteen healthy, male participants were recruited through local advertisement. All 
participants were healthy and non-smokers (28±5yrs, height 1.79±0.10m, weight 
78.3±8.5kg, BMI 25±2kg/m2, mean arterial pressure (MAP) 79±5mmHg). Individuals 
with a medical history of hypercholesterolaemia (total cholesterol >6.5mmol/l),[19] 
cardiovascular disease and/or hypertension (systolic blood pressure ≥140mmHg, 
diastolic blood pressure ≥90mmHg) [20, 21] were excluded. Participants were not 
taking any vasoactive medications or supplements. After being fully informed of the 
 methods, written informed consent was obtained from all participants. The study 
conformed to the Declaration of Helsinki and was approved by the Research Ethics 
Committee of Liverpool John Moores University. 
 
Experimental Design 
All participants attended two experimental trials which were 2-7 days apart. During 
each trial, baseline and maximal thermally stimulated forearm cutaneous blood flow 
was examined simultaneously at four different sites on the dominant forearm using 
LDF. At each site, separated by ~5cm, a different local heating protocol was adopted: 
1. Rapid 39°C [11], 2. Rapid 42°C [10], 3. Gradual 42°C [8], and 4. Slow 42°C [8]. The 
sites at the forearm were kept the same within subjects between the two testing days. 
 
Experimental Measures 
All participants fasted for at least six hours and refrained from alcohol, food products 
high in polyphenols (dark chocolate, red wine), caffeine and exercise for 24h prior to 
testing [22]. Sips of water were permitted prior to testing to ensure that participants 
were well hydrated. All trials were conducted in a quiet, temperature controlled 
environment (23.0±0.4°C) [22, 23] and at the same time of day to reduce any circadian 
influences on vascular function [22, 24]. Stature (seca 217 stadiometer, seca UK, 
Birmingham, UK) and body mass (seca 767 calibrated electronic scales, Germany) 
were recorded using standardised protocols. Body mass index was calculated (BMI) 
as the body weight (kg) divided by the height squared (m2). 
 
 Following a 20-minute stabilisation period, the LDF equipment was calibrated using 
two generic points, 0 and 250 PU, a zeroing disk and motility standard, according to 
manufacturer’s guidelines (Perimed AB, Järfälla, Stockholm, Sweden). Participants 
assumed a comfortable, supine position on a bed, with the head slightly elevated and 
the dominant arm relaxed, supinated and supported by a vacuum cushion to minimise 
microcirculatory fluctuations resulting from motion artefact [22, 23]. Four measurement 
sites on the volar aspect of the dominant forearm were randomly chosen ≥2.5cm from 
the antecubital fossa and ≥2.5cm from the distal radio-ulnar joint at the wrist, avoiding 
visible veins, hair follicles and dermatological lesions [23]. If necessary, the 
measurement sites were shaved 24h prior to testing to avoid any inflammatory 
response that may affect cutaneous blood flow. Following a 20-minute rest period, 
participants were instrumented for LDF measurements; four heating discs (Perimed 
355, Perimed AB, Järfälla, Stockholm, Sweden) were placed ~5cm apart on the 
dominant forearm, with a 7-laser array probe (PF 413, Perimed AB, Järfälla, 
Stockholm, Sweden) placed into each heater and firmly attached to the skin using 
adhesive stickers. To ensure accuracy of measurement sites between trials, the 
relevant areas were marked on the skin following the first experimental trial. In addition, 
we took digital photographs and recorded measurements to the nearest millimetre 
using anatomical and skin-surface landmarks for reference.  
 
Cutaneous blood flow was measured as a signal of red blood cell flux (RBCF) using 
the non-invasive technique of LDF (Periflux system 5000, Perimed AB, Järfälla, 
Stockholm, Sweden). The four local heating discs were connected to a heating unit 
(Peritemp 4005 heater, Perimed AB, Järfälla, Stockholm, Sweden) which was used to 
induce thermal hyperaemia and was manually controlled during the local heating 
 protocols.  Baseline skin RBCF was recorded with the local heating disc temperature 
set at 33°C for 10-minutes for each measurement site. Subsequently, local skin 
temperature was heated according to four distinct protocols:  
Rapid 39°C [11]. This recently introduced protocol (0.5°C per 5s, 30-min at 39°C, 20-
min at 44°C) induces an axon-reflex and gradual plateau following local heating. By 
stopping the heating protocol at 39°C, the plateau phase is largely NO-mediated and 
causes dilation that is equivalent to 50% of the maximal response [11]. 
Rapid 42°C [10]. This classic local heating protocol (0.5°C per 5s, 30-min at 42°C, 20-
min at 44°C) induces a rapid, transient axon-reflex which is followed by a more gradual, 
but sustained, heating response. The plateau phase represents 80-90% of the 
maximal response, and is partly (60-70%) NO-mediated [10, 25].  
Gradual 42°C [8]. This adapted, shortened version of the Slow 42°C local heating 
protocol increases temperature to 42°C (0.5°C per 2-min 30s, 30-min at 42°C, 20-min 
at 44°C), and induces a slow heating response that is largely NO-mediated and 
reflects 80-90% of the maximal response [8].  
Slow 42°C [8]. This validated, longer version of the former heating protocol induces a 
gradual, slow heating response (0.5°C per 5-min, 30-min at 42°C, 20-min at 44°C) that 
is largely NO-mediated, reflecting 80-90% of the maximal response.  
 
Haemodynamics. Heart rate (HR) and blood pressure (BP) were recorded at the 
beginning and at the end of the 20-minute acclimation period using an automated 
sphygmomanometer (Dinamap V100, GE Healthcare, UK) positioned on the 
contralateral upper arm. Thereafter, MAP (mmHg) and HR (bpm) were recorded at 5-
minute intervals throughout the local heating protocols. MAP was used to calculate 
 cutaneous vascular conductance (CVC; RBCF/MAP), thereby accounting for changes 
in skin blood flow resulting from variations in BP [10, 12, 23].  
 
Data Analysis  
Cutaneous RBCF was indexed as perfusion units (PU) and represents local cutaneous 
blood flow, which was subsequently expressed as cutaneous vascular conductance 
(CVC), as described previously [23]. Artefact in the data, due to unwanted subject 
movement, was identified and removed prior to analysis. Baseline laser Doppler flux 
was averaged over a stable 10-minute period. The plateau phases during heating 
(39/42°C and 44°C) were averaged over the last 5-minutes of each protocol. Data at 
baseline and at the various plateau phases were also normalised to the maximal flux 
achieved at 44°C (%CVCmax = [CVC / CVCmax] x 100). All data were collected in 
LabChart 7.0 (ADInstruments, Dunedin, New Zealand). 
 
Statistical Methods  
Data were expressed as mean±SD and statistical significance was set at P<0.05. 
Mixed model RMANOVA was used to compare local heating protocols and paired 
Student’s t-tests were used to examine day-to-day systematic bias of each local 
heating protocol. Bland-Altman plots were constructed to demonstrate individual 
variability. The coefficient of variation (CV) was calculated to assess the inter-day 
reproducibility of CVC and %CVCmax at baseline, 39/42°C and 44°C. Prior to 
calculating the CV, a natural logarithmic transformation was applied to correct for 
heteroscedasticity of the data. For biological variables, a CV of <10% is considered 
good and <20% is acceptable [26]. A two-way ANOVA was used to examine BP within 
 each protocol and between test days (main effects of local temperature and visit). Data 
were stored and transformed within Microsoft Excel (Microsoft Office 2010, Microsoft 
Corporation), and statistical analyses were performed using SPSS 22.0 (SPSS, 
Chicago, IL, USA). 
 
RESULTS 
Figure 1 shows representative skin blood flow traces for all local heating protocols, 
indicating the phases and associated local temperatures (33°C, 39/42°C and 44°C) 
that were used for analysis. There was a small but significant increase in MAP during 
the heating protocols (P=0.002), consistent with a circadian variation. This gradual 
increase in MAP was not different between trials (P=0.39) and no interaction effect 
was found between local temperature and trial (P=0.49).  
 
Baseline. Baseline cutaneous blood flow was not different between days when 
expressed as arbitrary flux or CVC (all P>0.05, Table 1). Also when expressed as 
%CVCmax, cutaneous blood flow was not different between days for the heating sites 
for Rapid 39°C, Rapid 42°C, Gradual 42°C or Slow 42°C (Table 1). Inter-day variation 
of baseline cutaneous blood flow was 17.2-26.1% for flux, 17.4-24.8% for CVC and 
18.6-29.2% for %CVCmax (Table 1), with no differences between local heating sites.  
 
Local heating to plateau (39/42°C). For all four protocols, inter-day cutaneous 
perfusion at the plateau phase was not different between days when expressed as 
arbitrary flux, CVC or %CVCmax (all P>0.05, Table 2). Lower inter-day reproducibility 
 was found for the plateau phase of Rapid 39°C compared to Rapid 42°C, Gradual 
42°C and Slow 42°C when data were expressed as flux, CVC or %CVCmax (Table 2). 
When data were presented as %CVCmax, CV was lower for Rapid 42°C, Gradual 42°C 
and Slow 42°C (Table 2). Bland-Altman plots demonstrated no obvious 
heteroscedasticity for the responses at the plateau phase (Figure 2).  
 
Maximal heating. Perfusion, presented as flux of CVC, during maximal heating (44°C) 
was not different between days (Table 2). The maximum heating response resulted in 
a reproducibility of 12.3-15.0% when data were expressed as arbitrary flux and CVC 
(Table 2). This observation was valid across all four protocols. Bland-Altman plots 
demonstrated no obvious heteroscedasticity for the responses during maximal heating 
(Figure 3). 
 
 
DISCUSSION 
The aim of this study was to explore the inter-day reproducibility of four commonly 
used (and simultaneously performed) local skin heating protocols for assessing 
cutaneous vascular function. Our findings suggest that inter-day variation of baseline 
cutaneous blood flow demonstrated poor-to-moderate reproducibility. Secondly, inter-
day reproducibility of cutaneous blood flow responses to the plateau phase of the 
Rapid 42°C, Gradual 42°C and Slow 42°C protocols was moderate for flux and CVC, 
but good when data were presented after correcting for maximal perfusion (%CVCmax). 
In contrast, inter-day reproducibility of perfusion during the plateau phase of the Rapid 
39°C protocol was moderate-to-poor. Finally, maximal inter-day cutaneous blood flow 
demonstrated moderate reproducibility for arbitrary flux and CVC across all protocols, 
 which indicates that the maximum response was not affected by the preceding 
protocol of local heating. These observations have clinical impact for designing future 
studies, especially when multiple local heating protocols are being used 
simultaneously. 
 
Protocols that locally heat the skin in combination with LDF are frequently used to 
assess microvascular integrity and index overall systemic vascular function [4]. 
Current protocols vary in methodology with fast [10, 11] or gradual [8, 12] rates of skin 
heating. Although studies have explored the reproducibility of individual heating 
protocols, the current study is the first to simultaneously assess reproducibility of 
multiple protocols. This is particularly important given that the simultaneous 
assessment of cutaneous vascular function using these distinct heating protocols may 
achieve better insight due to the distinct dilator pathways involved. Firstly, we found 
moderate-to-poor reproducibility for baseline perfusion, in agreement with our, and 
others, previous research [12, 18]. It is important to acknowledge that the 
reproducibility of baseline perfusion was independent of the site of measurement (i.e. 
the four different sites that underwent the distinct heating protocols). Similarly, 
maximal perfusion at 44°C also demonstrated good agreement between the four 
measurement sites. This demonstrates that the reproducibility of the LDF technique to 
assess baseline or maximal perfusion is not dependent on the site of measurement, 
but also was not affected by the local heating protocol (e.g. rapid or gradual). 
 
Although distinct heating protocols were used, we expected a comparable 
reproducibility for the plateau phase according to previous studies [12, 18]. In line with 
 our hypothesis, but also in agreement with previous studies [12, 18], moderate 
reproducibility was found for perfusion during the plateau phases of the Rapid 42°C, 
Gradual 42°C and Slow 42°C protocols. Again consistent with previous studies [12, 
18], expressing data as a percentage of maximal perfusion resulted in an improvement 
of reproducibility. As CVC data is typically normalised to maximum to account for the 
heterogeneity of cutaneous vessel density, this may explain the increased 
reproducibility when data were normalised to %CVCmax. The use of integrated probes 
in the current and aforementioned studies, which allow an examination of a greater 
surface area of skin, may have contributed to the good-to-moderate reproducibility. 
Indeed, previous work on local heating using single point LDF probes report lower 
reproducibility [15, 17].  
 
Despite the good agreement between the rapid, gradual and slow heating protocols to 
42°C, poorer reproducibility was reported for forearm cutaneous vascular responses 
to the rapid heating protocol to 39°C. The poorer reproducibility of the Rapid 39°C 
protocol cannot be simply explained by the speed of increasing local temperature, 
especially since reproducibility of the Rapid 42°C and Gradual 42°C protocols were 
similar. The Rapid 39°C protocol was developed in order to isolate NO-dependent 
dilation and/or allow a better assessment of perturbations that may improve 
microvascular function due to the levels of skin blood flow achieved at this local skin 
temperature (~50% maximum) compared to those at 42°C (~90% maximum) [11]. 
Differences in reproducibility between the Rapid 39°C protocol and the other protocols 
may therefore relate to the differences in the level of skin blood flow achieved in the 
protocols. Skin blood flow was lower at the plateau phase of the Rapid 39°C protocol 
(i.e. ~50% of the maximum response) relative to the plateau phases of the Rapid 42°C, 
 Gradual 42°C and Slow 42°C protocols (80-90% of the maximum response). Such 
levels may provide more space for variation in perfusion, despite correcting the level 
of perfusion for differences in the maximum perfusion at 44°C. One consequence of 
this observation is that a larger group size is required for the Rapid 39°C protocol 
compared to the other protocols to detect differences within subjects.  
 
Using our data from the present study, we calculated the sample sizes required to 
show significant changes in %CVCmax at 39/42°C for within subject comparisons (e.g., 
pre and post interventions; Table 3). Assuming a power of 80% (α=0.05), the Rapid 
39°C protocol would require 54 subjects to detect a 5.0% change in %CVCmax at 39°C 
compared to 27 subjects at 42°C for the Rapid 42°C protocol. Again, assuming a 
power of 80% (α=0.05), the Gradual 42°C protocol would require 17 subjects to detect 
a 5.0% change in %CVCmax at 42°C and the Slow 42°C protocol would require 47 
subjects. These sample size estimations demonstrate distinctly different requirements 
for studies that use both rapid and gradual local heating, possibly related to between 
protocol differences in underlying vasodilatory mechanisms. 
 
The reproducibility of the Rapid 42°C, Gradual and Slow 42°C protocols were similar. 
Importantly, these local heating protocols induce skin vasodilation via different 
mechanisms. Whilst slowly heating the skin prevents significant axon-reflexes and 
leads to a largely NO-mediated response, rapidly heating the skin activates the axon-
reflex and leads to a NO- and EDHF-mediated response [7]. The involvement of 
multiple vasoactive substances in the rapid heating response might have contributed 
to a larger variation in response to the Rapid 42°C local heating protocol. However, 
 similar coefficients of variation were evident for the CVC and %CVCmax data in the 
Rapid 42°C and Gradual 42°C protocols. The specific underlying pathways leading to 
vasodilation in response to the distinct heating protocols may therefore provide useful 
synergistic insight into complementary vasodilatory mechanisms. Therefore, 
supported by the comparable reproducibility, we suggest that measuring multiple local 
heating protocols is easy, applicable and feasible, but may also provide better insight 
into the skin vasodilator mechanisms. An alternative approach would be to use the 
same heating protocol across multiple sites to minimise any between-site 
differences. Averaging data across these sites would improve reliability and 
thereby reduce the sample size requirements. However, use of a single protocol 
is limited in only assessing one vasodilatory pathway, whereas a multi-protocol 
approach may elicit further mechanistic insight into vasodilatory responses 
observed.  
 
Limitations. We assessed inter-day reproducibility in a young, healthy population, 
thereby limiting extrapolation of our findings to individuals and patient groups with 
cardiovascular risk, such as older individuals, who commonly exhibit attenuated 
cutaneous blood flow responses to local heating [1, 8, 23, 27]. However, young and 
older subjects demonstrated comparable reproducibility of local heating in a previous 
study [18]. A further limitation is that females were excluded from this study to control 
for hormonal influences on vascular function [28-30] and, therefore, our findings are 
applicable to males only.  
 
 In conclusion, this is the first study to simultaneously examine the inter-day 
reproducibility of four local heating protocols, which are currently frequently used to 
assess cutaneous blood flow in humans. Our findings suggest that the reproducibility 
of baseline forearm skin perfusion assessment is poor to moderate, and is 
independent of the site of measurement. The Rapid, Gradual and Slow 42°C protocols 
exhibited superior reproducibility, particularly when data is expressed as %CVCmax, 
compared to the Rapid 39°C protocol. Our data support the validity of repeated 
measures of cutaneous blood flow in response to local heating protocols, for use in 
epidemiological studies as an index of microvascular function. Furthermore, this data 
provides help in guiding future studies in calculating sample sizes necessary to detect 
differences, especially since differences are present between the different protocols. 
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 Table 1. Baseline cutaneous blood flow results. Data is presented as mean ± SD. 
Inter-day reproducibility is presented as CV (± 95% CI): light grey shading indicates 
CV: >21%; mid grey shading indicates CV: 10-20%.  
 
 Trial 1  Trial 2  Between-day CV (%) Paired t-test 
Baseline (33°C)        
Rapid 39°C         
    Absolute flux (PU) 21 ± 10 20 ± 9  26.1 (19.1 - 41.3)  0.57 
    Absolute CVC (PU/mmHg) 0.26 ± 0.12 0.25 ± 0.11 24.8 (18.2 - 39.2) 0.66 
    Maximal CVC (%CVCmax) 9 ± 5 8 ± 4 29.2 (21.4 - 46.5) 0.51 
Rapid 42°C         
    Absolute flux (PU) 20 ± 9 19 ± 10 17.2 (12.6 - 26.8) 0.10 
    Absolute CVC (PU/mmHg) 0.26 ± 0.11 0.24 ± 0.13 17.4 (12.8 - 27.2) 0.26 
    Maximal CVC (%CVCmax) 8 ± 4 8 ± 5 19.3 (14.2 - 30.3) 0.66 
Gradual 42°C         
    Absolute flux (PU) 19 ± 8  20 ± 12 19.9 (14.6 - 31.2)  0.93 
    Absolute CVC (PU/mmHg) 0.24 ± 0.10 0.25 ± 0.15 20.8 (15.3 - 32.7) 0.79 
    Maximal CVC (%CVCmax) 7 ± 4 7 ± 4 18.6 (13.7 - 29.2) 0.89 
Slow 42°C         
    Absolute flux (PU) 25 ± 11  22 ± 10   21.1 (15.5 - 33.2)  0.30 
    Absolute CVC (PU/mmHg) 0.31 ± 0.14 0.28 ± 0.12 22.7 (16.7 - 35.7) 0.43 
    Maximal CVC (%CVCmax) 10 ± 4 9 ± 5 24.7 (18.2 - 39.1) 0.73 
  
 Table 2. Local heating cutaneous blood flow results. Data is presented as mean ± SD. 
Inter-day reproducibility is presented as CV (± 95% CI): light grey shading indicates 
CV: >21%; mid grey shading indicates CV: 10-20%; dark grey shading indicates 
CV<10%. 
 
 Trial 1  Trial 2  Between-day CV (%) Paired t-test 
Plateau Phase (39°C /42°C)        
Rapid 39°C         
    Absolute flux (PU) 138 ± 56 150 ± 57 20.6 (15.1 - 32.3) 0.20 
    Absolute CVC (PU/mmHg) 1.76 ± 0.67 1.93 ± 0.76 21.2 (15.6 - 33.4) 0.22 
    Maximal CVC (%CVCmax) 55 ± 16 57 ± 13 20.7 (15.2 - 32.6) 0.48 
Rapid 42°C         
    Absolute flux (PU) 233 ± 56 218 ± 45 13.1 (9.7 - 20.5)  0.15 
    Absolute CVC (PU/mmHg) 3.01 ± 0.73 2.80 ± 0.56 12.8 (9.5 - 20.0) 0.09 
    Maximal CVC (%CVCmax) 87 ± 8 86 ± 7 6.8 (5.0 - 10.5) 0.56 
Gradual 42°C         
    Absolute flux (PU) 240 ± 35 242 ± 54 15.2 (11.2 - 23.7)  0.87 
    Absolute CVC (PU/mmHg) 3.00 ± 0.51 3.07 ± 0.69 15.9 (11.7 - 24.9) 0.69 
    Maximal CVC (%CVCmax) 88 ± 4 90 ± 6 5.2 (3.9 - 8.1) 0.29 
Slow 42°C         
    Absolute flux (PU) 220 ± 47 231 ± 52 16.6 (12.3 - 26.0) 0.48 
    Absolute CVC (PU/mmHg) 2.61 ± 0.54 2.81 ± 0.63 18.2 (13.4 - 28.4) 0.26 
    Maximal CVC (%CVCmax) 81 ± 11 87 ± 11 10.6 (7.8 - 16.5) 0.09 
Maximal Plateau (44°C)        
Rapid 39°C         
    Absolute flux (PU) 255 ± 49 261 ± 61 12.9 (9.5 - 20.0)  0.66 
    Absolute CVC (PU/mmHg) 3.22 ± 0.60 3.37 ± 0.82 13.2 (9.8 - 20.6) 0.38 
Rapid 42°C         
    Absolute flux (PU) 274 ± 62 254 ± 42 13.7 (10.1 - 21.3)  0.11 
    Absolute CVC (PU/mmHg) 3.46 ± 0.75 3.26 ± 0.55 12.3 (9.1 - 19.2) 0.14 
Gradual 42°C         
    Absolute flux (PU) 274 ± 42 275 ± 60 14.6 (10.8 - 22.8)  0.96 
    Absolute CVC (PU/mmHg) 3.39 ± 0.50 3.41 ± 0.74 14.5 (10.7 - 22.6) 0.93 
Slow 42°C         
    Absolute flux (PU) 274 ± 47 268 ± 54 13.2 (9.8 - 20.6)  0.71 
    Absolute CVC (PU/mmHg) 3.21 ± 0.58 3.23 ± 0.61 15.0 (11.1 - 23.5) 0.89 
 
  
 Table 3. Estimated sample sizes required for a repeated measures study design using the Rapid 39°C, Rapid 42°C, Gradual 42°C 
and Slow 42°C local heating protocols to detect significant changes in skin blood flow assessed as %CVCmax at 39/42°C using the 
results from the reproducibility study.  
       
Power, % α-Error Change in %CVCmax Sample size 
   Rapid 39°C Rapid 42°C Gradual 42°C Slow 42°C 
         
80 0.05 2.5 208 99 58 180 
80 0.05 5.0 54 27 17 47 
80 0.05 7.5 25 13 9 22 
80 0.05 10.0 15 9 6 14 
90 0.05 2.5 278 132 77 240 
90 0.05 5.0 71 35 21 62 
90 0.05 7.5 33 17 11 29 
90 0.05 10.0 20 11 7 17 
       
 FIGURE LEGENDS 
Figure 1.A. A representative forearm cutaneous arbitrary flux response for the four 
local heating protocols. Average flux was calculated over a stable 10-min period of 
baseline at 33°C (A) and the final 5-min of the plateau phases during heating at 
39/42°C (B and C, respectively) and 44°C (D). The spike (#) indicates artefact resulting 
from slight movement of the arm which was removed prior to analysis. B. Step-wise 
temperature increments with corresponding times for all four local heating protocols.  
 
Figure 2. Bland–Altman plots of the difference between days in %CVCmax against the 
mean of the measurements at the 39/42°C plateau for A. Rapid 39°C, B. Rapid 42°C, 
C. Gradual 42°C and D. Slow 42°C. Middle horizontal line denotes mean value and 
upper and lower lines denote 95% limits of agreement. Linear regression 
demonstrated no evidence of proportional bias. 
 
Figure 3. Bland–Altman plots of the difference between days in CVC against the mean 
of the measurements at 44°C for A. Rapid 39°C, B. Rapid 42°C, C. Gradual 42°C and 
D. Slow 42°C. Middle horizontal line denotes mean value and upper and lower lines 
denote 95% limits of agreement. Linear regression demonstrated no evidence of 
proportional bias. 
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